Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real‐world retrospective study

Documenti analoghi

• Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide ( SEMA ‐elderly)
  di: Vincenzo Fiore, et al.
  Pubblicazione: (2025)
• Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER ‐2 trial emulation with real‐world data
  di: Gian Paolo Fadini, et al.
  Pubblicazione: (2025)
• Effect of semaglutide add‐on therapy for people living with type 1 diabetes and excess weight
  di: Noga C. Minsky, et al.
  Pubblicazione: (2025)
• The effect of semaglutide on intestinal iron absorption in patients with type 2 diabetes mellitus—A pilot study
  di: Petra Melis, et al.
  Pubblicazione: (2025)
• Real‐world safety profile of once‐weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real‐world Evidence (SURE) programme
  di: Jean‐François Yale, et al.
  Pubblicazione: (2024)